SEC 13F Intelligence

Managers / Q4 2022 · view latest →

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

CIK 0001553936 · SUITES 818-822, 8/F, BANK OF AMERICA, TOWER, 12 HARCOURT ROAD,, HONG KONG, K3, XXXXX · 852-3983-6800

Reported Value
$1.0B
Q4 2022
Positions
27
Filings on Record
29
2019–present window
Filed
Feb 14, 2023
original filing

Summary

Tybourne Capital Management (Hk) Ltd reported $1.0B in U.S.-listed holdings across 27 positions for Q4 2022.

Its largest position, V, represents 9.1% of the portfolio.

Compared with Q3 2022, the fund opened 2 new positions and exited 1.

Portfolio Metrics

Turnover
+13.4%
vs prior filed quarter
Top-10 Concentration
+66.1%
share of reported value
Largest Position
+9.1%
Visa Inc Shares V US
New / Exited
2 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.2BQ4 ’18Q1 ’19: $2.6BQ2 ’19: $2.8BQ3 ’19: $2.3BQ4 ’19: $2.6BQ4 ’19Q1 ’20: $2.7BQ2 ’20: $3.3BQ3 ’20: $4.1BQ4 ’20: $4.8BQ4 ’20Q1 ’21: $4.6BQ2 ’21: $4.7BQ3 ’21: $4.0BQ4 ’21: $3.4BQ4 ’21Q1 ’22: $1.7BQ2 ’22: $1.4BQ3 ’22: $1.0BQ4 ’22: $1.0BQ4 ’22Q1 ’23: $993MQ2 ’23: $925MQ3 ’23: $716MQ4 ’23: $671MQ4 ’23Q1 ’24: $585MQ2 ’24: $492MQ3 ’24: $357MQ4 ’24: $398MQ4 ’24Q1 ’25: $24MQ2 ’25: $35MQ3 ’25: $31Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 68.8%ADR: 15.8%Other: 15.5%
  • Common Stock · 68.8% · $690M
  • ADR · 15.8% · $158M
  • Other · 15.5% · $155M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
METAMETA PLATFORMS INC-CLASS A (META US)NEW+382.7K382.7K+$46M$46M
IQVIQVIA HOLDINGS INC (IQV US)NEW+133.3K133.3K+$27M$27M
TSHATAYSHA GENE THERAPIES INC (TSHA US)ADDED+1.00M1.50M+$2M$3M
QCOMQUALCOMM INC (QCOM US)SOLD OUT−270.1K0−$31M$0
INHIBRX INC (INBX US)TRIMMED−550.2K95.7K−$9M$2M
TWLOTWILIO INC - A (TWLO US)TRIMMED−202.6K197.6K−$18M$10M
LAM RESEARCH CORP (LRCX US)TRIMMED−61.4K63.2K−$19M$27M
NVDANVIDIA CORP (NVDA US)TRIMMED−175.4K186.1K−$17M$27M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2022

27 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1VVISA INC-CLASS A SHARES (V US)history →COM CL A9.12%$92M440.6K
2CANADIAN PACIFIC RAILWAY LTD (CP US)COM8.36%$84M1.12M
3SPGIS&P GLOBAL INC (SPGI US)history →COM7.45%$75M223.1K
4LINDE PLC (LIN US)SHS7.10%$71M218.2K
5MSFTMICROSOFT CORP (MSFT US)history →COM7.05%$71M295.0K
6AMZNAMAZON.COM INC (AMZN US)history →COM6.88%$69M822.3K
7MELIMERCADOLIBRE INC (MELI US)history →COM5.88%$59M69.7K
8HTHTH WORLD GROUP LTD (HTHT US)history →SPONSORED ADS5.21%$52M1.23M
9METAMETA PLATFORMS INC-CLASS A (META US)history →CL A4.59%$46M382.7K
10ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)history →COM4.48%$45M2.23M
11BEKEKE HOLDINGS INC-ADR (BEKE US)history →SPONSORED ADS4.32%$43M3.10M
12SHOPSHOPIFY INC - CLASS A (SHOP US)history →CL A3.43%$34M992.0K
13SESEA LTD-ADR (SE US)history →SPONSORD ADS3.01%$30M581.1K
14IQVIQVIA HOLDINGS INC (IQV US)history →COM2.72%$27M133.3K
15NVDANVIDIA CORP (NVDA US)history →COM2.71%$27M186.1K
16BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)history →SPONSORED ADS2.67%$27M905.7K
17LAM RESEARCH CORP (LRCX US)COM2.65%$27M63.2K
18XYZBLOCK INC (SQ US)history →CL A2.61%$26M417.2K
19STNESTONECO LTD-A (STNE US)history →COM CL A2.47%$25M2.63M
20TXNTEXAS INSTRUMENTS INC (TXN US)history →COM1.63%$16M98.8K
21SNOWSNOWFLAKE INC-CLASS A (SNOW US)history →CL A1.45%$14M101.0K
22MDBMONGODB INC (MDB US)history →CL A1.33%$13M67.6K
23TWLOTWILIO INC - A (TWLO US)CL A0.96%$10M197.6K
24TEAMATLASSIAN CORP -CLASS A (TEAM US)CL A0.79%$8M61.9K
25LIANYLIANBIO-ADR (LIAN US)SPONSORED ADS0.54%$5M3.30M
26TSHATAYSHA GENE THERAPIES INC (TSHA US)COM SHS0.34%$3M1.50M
27INHIBRX INC (INBX US)COM0.23%$2M95.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$31M4Nov 6, 202513F-HRchanges · EDGAR ↗
Q2 2025$35M6Aug 1, 202513F-HRchanges · EDGAR ↗
Q1 2025$24M5May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$398M37Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$357M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$492M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$585M41May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$671M39Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$716M41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$925M49Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$993M49May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B27Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.0B26Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B27Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.7B30May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$3.4B26Feb 25, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$4.0B24Oct 27, 202113F-HRchanges · EDGAR ↗
Q2 2021$4.7B29Jul 22, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.6B32Apr 13, 202113F-HRchanges · EDGAR ↗
Q4 2020$4.8B31Feb 11, 202113F-HRchanges · EDGAR ↗
Q3 2020$4.1B29Nov 9, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B21Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.7B21May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$2.6B13Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.3B12Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$2.8B13Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$2.6B11May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.2B9Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.